Journal list menu
Export Citations
Download PDFs
Editorials
Free Access
free
Screening for hepatocellular carcinoma: The rationale for the American Association for the Study of Liver Diseases recommendations†
- Pages: 793-796
- First Published: 11 June 2012
Free Access
free
NS5A: A new target for antiviral drugs in the treatment of hepatitis C virus infection†
- Pages: 797-799
- First Published: 05 March 2012
Free Access
free
The prognosis of perihilar cholangiocarcinoma after radical treatments†‡
- Pages: 800-802
- First Published: 24 April 2012
Viral Hepatitis
Free Access
free
MxA inhibits hepatitis B virus replication by interaction with hepatitis B core antigen†
- Pages: 803-811
- First Published: 23 January 2012
Free Access
free
A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearance†‡
- Pages: 812-819
- First Published: 15 March 2012
Free Access
free
Transcriptomic analysis of the woodchuck model of chronic hepatitis B†‡§
- Pages: 820-830
- First Published: 20 March 2012
Free Access
free
Hepatitis C virus infection enhances TNFα-induced cell death via suppression of NF-κB†
- Pages: 831-840
- First Published: 20 March 2012
Free Access
free
Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection†‡
- Pages: 841-849
- First Published: 20 March 2012
Free Access
free
Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C†
- Pages: 850-860
- First Published: 27 March 2012
Free Access
free
Efficient replication of primary or culture hepatitis C virus isolates in human liver slices: A relevant ex vivo model of liver infection†‡
- Pages: 861-872
- First Published: 27 March 2012
Free Access
free
Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice†
- Pages: 873-883
- First Published: 06 April 2012
Free Access
free
Vaniprevir with pegylated interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C: A randomized phase II study†
- Pages: 884-893
- First Published: 02 April 2012
Steatohepatitis/Metabolic Liver Disease
Free Access
free
Specific immunization strategies against oxidized low-density lipoprotein: A novel way to reduce nonalcoholic steatohepatitis in mice†‡
- Pages: 894-903
- First Published: 15 February 2012
Free Access
free
Clinical cofactors and hepatic fibrosis in hereditary hemochromatosis: The role of diabetes mellitus†‡
- Pages: 904-911
- First Published: 15 March 2012
Free Access
free
Hydrogen-rich water prevents progression of nonalcoholic steatohepatitis and accompanying hepatocarcinogenesis in mice†
- Pages: 912-921
- First Published: 13 April 2012
Open Access
oa
Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: A randomized controlled trial †
- Pages: 922-932
- First Published: 20 March 2012
Free Access
free
Nonalcoholic steatohepatitis versus steatosis: Adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism †
- Pages: 933-942
- First Published: 08 June 2012
Free Access
free
Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis†‡
- Pages: 943-951
- First Published: 13 April 2012
Free Access
free
Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes†‡§
- Pages: 952-960
- First Published: 29 March 2012
Free Access
free
Ferroportin1 in hepatocytes and macrophages is required for the efficient mobilization of body iron stores in mice†
- Pages: 961-971
- First Published: 02 April 2012
Hepatobiliary Malignancies
Free Access
free
Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma† ‡
- Pages: 972-981
- First Published: 30 January 2012
Free Access
free
S-adenosyl methionine regulates ubiquitin-conjugating enzyme 9 protein expression and sumoylation in murine liver and human cancers†
- Pages: 982-993
- First Published: 10 March 2012
Free Access
free
Characteristic patterns of altered DNA methylation predict emergence of human hepatocellular carcinoma†
- Pages: 994-1003
- First Published: 12 March 2012
Free Access
free
Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma†‡
- Pages: 1004-1014
- First Published: 02 April 2012
Free Access
free
Hepatitis B virus X protein stabilizes amplified in breast cancer 1 protein and cooperates with it to promote human hepatocellular carcinoma cell invasiveness†
- Pages: 1015-1024
- First Published: 02 April 2012
Free Access
free
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model†
- Pages: 1025-1033
- First Published: 02 April 2012
Autoimmune, Cholestatic and Biliary Disease
Free Access
free
Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice†
- Pages: 1034-1043
- First Published: 29 March 2012
Liver Failure/Cirrhosis/Portal Hypertension
Free Access
free
Immediate intraportal transplantation of human bone marrow mesenchymal stem cells prevents death from fulminant hepatic failure in pigs†
- Pages: 1044-1052
- First Published: 16 March 2012
Free Access
free
Hepatic vein arrival time as assessed by contrast-enhanced ultrasonography is useful for the assessment of portal hypertension in compensated cirrhosis†
- Pages: 1053-1062
- First Published: 02 April 2012
Liver Injury/Regeneration
Free Access
free
Human mesenchymal stem cells are recruited to injured liver in a β1-integrin and CD44 dependent manner†
- Pages: 1063-1073
- First Published: 15 March 2012
Free Access
free
TIMP-1 deficiency leads to lethal partial hepatic ischemia and reperfusion injury†‡
- Pages: 1074-1085
- First Published: 12 March 2012
Free Access
free
Distinct contribution of human cord blood-derived endothelial colony forming cells to liver and gut in a fetal sheep model†
- Pages: 1086-1096
- First Published: 04 April 2012
Open Access
oa
Yes-associated protein regulates the hepatic response after bile duct ligation†
- Pages: 1097-1107
- First Published: 08 August 2012
Liver Biology/Pathobiology
Open Access
oa
Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans†
- Pages: 1108-1116
- First Published: 05 April 2012
Free Access
free
Hepatic activation of IKK/NFκB signaling induces liver fibrosis via macrophage-mediated chronic inflammation†‡
- Pages: 1117-1128
- First Published: 12 March 2012
Open Access
oa
Histone methyltransferase ASH1 orchestrates fibrogenic gene transcription during myofibroblast transdifferentiation†
- Pages: 1129-1139
- First Published: 04 April 2012
Free Access
free
Cyclin E1 controls proliferation of hepatic stellate cells and is essential for liver fibrogenesis in mice†
- Pages: 1140-1149
- First Published: 27 March 2012
Free Access
free
Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice†
- Pages: 1150-1159
- First Published: 02 April 2012
Reviews
Free Access
free
Congenital heart disease and the liver†
- Pages: 1160-1169
- First Published: 02 March 2012
Hepatology Elsewhere
Free Access
free
Rapid response activatable molecular probes for intraoperative optical image-guided tumor resection†
- Pages: 1170-1173
- First Published: 26 June 2012
Free Access
free
Liver repercussions of defective gut surveillance†
- Pages: 1174-1177
- First Published: 28 August 2012
Clinical Observations in Hepatology
Free Access
free
HNF1B deficiency causes ciliary defects in human cholangiocytes†
- Pages: 1178-1181
- First Published: 18 June 2012
Correspondence
Free Access
free
Antiannexin V antibodies: An underestimated source of noncirrhotic portal vein thrombosis?†
- Page: 1182
- First Published: 28 February 2012
Free Access
free
H3 or H4 histamine receptors: That which contributes to suppressing human cholangiocarcinoma progression still remains to be clarified†
- Pages: 1182-1183
- First Published: 28 February 2012
Free Access
free
Reply: H3 or H4 histamine receptors: That which contributes to suppressing human cholangiocarcinoma progression still remains to be clarified†
- Page: 1183
- First Published: 28 February 2012
Free Access
free
Does reference value of “Normal Liver Stiffness” using fibroscan have a regional variation?†
- Pages: 1183-1184
- First Published: 15 March 2012
Free Access
free
Reply: Does reference value of “Normal Liver Stiffness” using fibroscan have a regional variation?†
- Pages: 1184-1185
- First Published: 15 March 2012
Free Access
free
Cardiovascular phenotype of nonalcoholic fatty liver disease: Hanging the paradigm about the role of distant toxic fat accumulation on vascular disease†
- Pages: 1185-1186
- First Published: 13 April 2012